Osteri 750mcg Solution for Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Teriparatide (750mcg)
Overview Osteri 750mcg Solution for Injection
Parathyroid hormone analog, Osteoject 750mcg injectable solution, treats severe osteoporosis and high fracture risk in men and postmenopausal women. Its mechanism involves stimulating bone growth, thereby increasing bone density and reducing spinal fracture probability. Administered subcutaneously or by a healthcare provider, Osteoject 750mcg requires daily, consistent self-injection for optimal efficacy. Treatment typically lasts up to two years, though your physician will determine the appropriate duration. Refrigerate between 2°C and 8°C. Common side effects may include arthralgia, injection site inflammation (pain, edema, erythema), and lower extremity spasms. Report persistent or bothersome side effects to your doctor. Prior to initiating therapy, disclose any kidney issues (including history of nephrolithiasis) as hypercalcemia or hypercalciuria may occur. Pregnant or lactating individuals should seek medical counsel before use. Your doctor might recommend bone densitometry to track treatment progress.
Uses of Osteri 750mcg Solution for Injection
Brittle bone disease
Major Benefits of Osteri 750mcg Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
Common Side effects of Osteri 750mcg Solution for Injection:
- Joint pain
- Injection site reactions (pain, swelling, redness)
- Nausea
- Leg cramps
How to use Osteri 750mcg Solution for Injection:
Medical professionals will instruct you on the proper administration of this medication.
How Osteri 750mcg Solution for Injection works:
Parathyroid hormone (PTH) analog, Osteri 750mcg injectable solution, stimulates osteoblast proliferation and activity, thereby enhancing bone density and reducing fracture vulnerability.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Osteri 750mcg Injection Solution with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Administering Osteri 750mcg Injection Solution during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of 750mcg Osteri injectable solution with breastfeeding is absent. Seek medical advice.
DrivingUNSAFE
Administering Osteri 750mcg Injection may cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these side effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should receive Osteri 750mcg Injection with close monitoring. Dosage modification may be necessary for such patients. Medical advice is recommended. Osteri 750mcg Injection is contraindicated in those with severely compromised renal function.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Osteri 750mcg injectable solution to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Osteri 750mcg Solution for Injection :
Should you forget a dose of injectable Osteri 750mcg, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Osteri 750mcg Solution for Injection
| Label | Value |
|---|---|
| Chemical Category | Parathyroid Hormone-Related Peptides |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
3,018 People bought this recently